Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06987045) titled 'Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study' on May 15.
Study Type: Observational
Primary Sponsor: Queen Mary University of London
Condition:
Prostate CA
Recruitment Status: Not recruiting
Date of First Enrollment: August 1, 2025
Target Sample Size: 500
To know more, visit https://clinicaltrials.gov/ct2/show/NCT06987045
Disclaimer: Curated by HT Syndication....